Infection
Symposium
ERS and tuberculosis
2016 highlights (followed by WHO/ERS Document ceremony)
Aims : This symposium will highlight some of the core achievement in Tuberculosis prevention and control. The focus will be on tuberculosis projects which involved ERS.
Specific objectives are to inform the audience about the new ATS guidelines (which had been developed in collaboration with ERS) and the requisite that new treatment regimens for TB need to have (Target Product Profiles-TPPs- as developed by WHO). During the session the new WHO document on new anti-TB regimens TPPs will be officially launched. Furthermore, the results of the WHO LTBI implementation plan and of the WHO/ERS digital health projects will be presented.
Target audience :
Allied health professional, Clinician, Epidemiologist, General practitioner, Fellow, Junior member, Microbiologist, Nurse, Paediatrician, Patient, Public health official, Pulmonologist, Trainee, TB specialist, Scientist, Respiratory physician, Researcher
10:45
The new ATS and ERS TB treatment guidelines
P. Nahid(San Francisco, United States)
COI
1
425
11:10
The new WHO TPPs (Target Product Profiles) for new TB treatment regimens
C. Lienhardt(Genève 27, Switzerland)
COI
2
426
11:35
Scaling-up global implementation of LTBI management: a paradigm shift needed
H. Getahun(Genève, Switzerland)
COI
3
427
12:00
Motivating TB patients via mobiles: today's evidence and tomorrow's
D. Falzon(Genève, Switzerland)
COI
4
428
12:25
ERS Tuberculosis working group
I. Solovic(Vysne Hagy, Slovakia)
COI
5
429
12:45
Ceremony for ERS/WHO Document
6
430
. . .